Marguerite M. Conley

Dr. Marguerite M. Conley

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2017 in Nutrition & Dietetics
Verified
Journal Article
Closed access
PDF file
MCMarguerite M. Conley
Marguerite M. Conley
LFLauren Le Fevre
Lauren Le Fevre
CHCilla Haywood
Cilla Haywood
JPJoseph Proietto
Joseph Proietto

30 March 2021 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MCMarguerite M. Conley
Marguerite M. Conley
CMCatherine M McFarlane
Catherine M McFarlane
DJDavid W Johnson
David W Johnson
JKJaimon T Kelly
Jaimon T Kelly
KCKatrina L Campbell
Katrina L Campbell
HMHelen L MacLaughlin
Helen L MacLaughlin

19 December 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
HMHelen L MacLaughlin
Helen L MacLaughlin
EMErynn McAuley
Erynn McAuley
JFJessica Fry
Jessica Fry
EPElissa Pacheco
Elissa Pacheco
NMNatalie Moran
Natalie Moran
BMBelinda Mason
Belinda Mason
Potassium dysregulation can be life-threatening. Dietary potassium modification is a management strategy for hyperkalaemia. However, a 2017 review for clinical guidelines found no trials evaluating dietary restriction for managing hyperkalaemia in chronic kidney disease (CKD). Evidence regarding dietary hyperkalaemia management was reviewed and practice recommendations disseminated. A literature search using terms for potassium, hyperkalaemia, and CKD was undertaken from 2018 to October 2022. Researchers extracted data, discussed findings, and formulated practice recommendations. A consumer resource, a clinician education webinar, and workplace education sessions were developed. Eighteen studies were included. Observational studies found no association between dietary and serum potassium in CKD populations. In two studies, 40–60 mmol increases in dietary/supplemental potassium increased serum potassium by 0.2–0.4 mmol/L. No studies examined lowering dietary potassium as a therapeutic treatment for hyperkalaemia. Healthy dietary patterns were associated with improved outcomes and may predict lower serum potassium, as dietary co-factors may support potassium shifts intracellularly, and increase excretion through the bowel. The resource recommended limiting potassium additives, large servings of meat and milk, and including high-fibre foods: wholegrains, fruits, and vegetables. In seven months, the resource received > 3300 views and the webinar > 290 views. This review highlights the need for prompt review of consumer resources, hospital diets, and health professionals’ knowledge.

28 July 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
RBRiley C C Brown
Riley C C Brown
DJDev Krish Jegatheesan
Dev Krish Jegatheesan
MCMarguerite M. Conley
Marguerite M. Conley
Hannah L MayrHannah L Mayr
Hannah L Mayr
JKJaimon T Kelly
Jaimon T Kelly
IHIngrid Hickman
Ingrid Hickman
Background: The metabolic syndrome is common across many complex chronic disease groups. Advances in health technology have provided opportunities to support lifestyle interventions. Objective: The purpose of this study is to test the feasibility of a health technology-assisted lifestyle intervention in a patient-led model of care. Methods: The study is a single-center, 26-week, randomized controlled trial. The setting is specialist kidney and liver disease clinics at a large Australian tertiary hospital. The participants will be adults with a complex chronic condition who are referred for dietetic assessment and display at least one feature of the metabolic syndrome. All participants will receive an individualized assessment and advice on diet quality from a dietitian, a wearable activity monitor, and standard care. Participants randomized to the intervention group will receive access to a suite of health technologies from which to choose, including common base components (text messages) and optional components (online and mobile app–based nutrition information, an online home exercise program, and group-based videoconferencing). Exposure to the optional aspects of the intervention will be patient-led, with participants choosing their preferred level of engagement. The primary outcome will be the feasibility of delivering the program, determined by safety, recruitment rate, retention, exposure uptake, and telehealth adherence. Secondary outcomes will be clinical effectiveness, patient-led goal attainment, treatment fidelity, exposure demand, and participant perceptions. Primary outcome data will be assessed descriptively and secondary outcomes will be assessed using an analysis of covariance. This study will provide evidence on the feasibility of the intervention in a tertiary setting for patients with complex chronic disease exhibiting features of the metabolic syndrome. Results: The study was funded in 2019. Enrollment has commenced and is expected to be completed by June 2022. Data collection and follow up are expected to be completed by December 2022. Results from the analyses based on primary outcomes are expected to be submitted for publication by June 2023. Conclusions: The study will test the implementation of a health technology–assisted lifestyle intervention in a tertiary outpatient setting for a diverse group of patients with complex chronic conditions. It is novel in that it embeds patient choice into intervention exposure and will inform health service decision-makers in regards to the feasibility of scale and spread of technology-assisted access to care for a broader reach of specialist services. Trial Registration: Australian New Zealand Clinical Trial Registry ACTRN12620001282976; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378337 International Registered Report Identifier (IRRID): DERR1-10.2196/37556

6 September 2018 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MCMarguerite M. Conley
Marguerite M. Conley
CMCatherine M McFarlane
Catherine M McFarlane
HMHelen MacLaughlin
Helen MacLaughlin
DJDavid Johnson
David Johnson
KCKatrina L Campbell
Katrina L Campbell

1 January 2022 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
PDF file
MCMarguerite M. Conley
Marguerite M. Conley
KCKatrina L. Campbell
Katrina L. Campbell
CHCarmel M. Hawley
Carmel M. Hawley
NLNicole M. Lioufas
Nicole M. Lioufas
GEGrahame J. Elder
Grahame J. Elder
NTNigel D. Toussaint
Nigel D. Toussaint